Dyslipidemia Management

Is Placebo Still Ethical in Trials of Incretin Therapies? Cardiovascular–Kidney–Metabolic Syndrome Stages, Echocardiographic Characteristics, and Heart Failure Risk: The Atherosclerosis Risk in Communities Study Mechanisms of GLP-1 Receptor Agonists in HFpEF: Exploring Weight-Dependent and Independent Drivers of Therapeutic Benefit Lipoprotein(a): An Atherosclerotic Cardiovascular Disease Risk Factor That Can No Longer Be Ignored 2026 Guideline on the Management of Dyslipidemia Lp(a) in Focus: Breakthrough Therapies and Clinical Implications Screening Diagnosis and Management of Pediatric Hypertriglyceridemia Cellular Interactions and Immunometabolic Mechanisms in Heart Failure With Preserved Ejection Fraction: From Molecular Mechanisms to Clinical Evidence 2026 Heart Disease and Stroke Statistics Exploring Ceramide C16:0 as a Novel Biomarker and Therapeutic Target for Atherosclerosis